A Offidani Selected Research

Chemokine CCL27

5/2012	Serum and tissue CTACK/CCL27 chemokine levels in early mycosis fungoides may be correlated with disease-free survival following treatment with interferon alfa and psoralen plus ultraviolet A therapy.
12/2007	CTACK /CCL27 expression in psoriatic skin and its modification after administration of etanercept.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A Offidani Research Topics

Disease

23	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2022 - 10/2006
6	Atopic Dermatitis (Atopic Eczema) 08/2022 - 09/2011
6	Necrosis 01/2021 - 11/2000
5	Hyperhidrosis 01/2014 - 09/2004
4	COVID-19 08/2022 - 12/2020
4	Pain (Aches) 01/2021 - 10/2013
3	Hidradenitis Suppurativa 01/2021 - 12/2020
3	Arthritis (Polyarthritis) 01/2016 - 10/2007
3	Insulin Resistance 07/2013 - 10/2007
3	Wound Infection (Wound Infections) 11/2012 - 05/2011
3	Infections 05/2011 - 08/2009
2	Skin Diseases (Skin Disease) 11/2021 - 01/2016
2	Pruritus (Itching) 08/2021 - 09/2013
2	Actinic Keratosis 03/2020 - 02/2017
2	Chronic Urticaria 05/2019 - 05/2009
2	Body Weight (Weight, Body) 05/2017 - 11/2012
2	Neoplasms (Cancer) 05/2014 - 06/2000
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2013 - 10/2007
2	Wounds and Injuries (Trauma) 11/2012 - 05/2011
2	Surgical Wound Infection 08/2012 - 05/2011
2	Inflammation (Inflammations) 10/2007 - 10/2006
1	Eczema 08/2022
1	Chronic Disease (Chronic Diseases) 11/2021
1	Conjunctivitis 07/2021
1	Abscess 01/2021
1	Keratoacanthoma 01/2020
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020
1	Urticaria (Hives) 05/2019
1	Granuloma 09/2016
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2015
1	Genetic Predisposition to Disease (Genetic Predisposition) 08/2015
1	Stevens-Johnson Syndrome (Lyell's Syndrome) 08/2015
1	Pyoderma Gangrenosum 06/2015
1	Hemorrhage 05/2014
1	Muscle Weakness 10/2013
1	Hyperpigmentation 09/2013
1	Erythema 09/2013
1	Burns 09/2013

Drug/Important Bio-Agent (IBA)

6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2017 - 11/2000
6	Etanercept (Enbrel)FDA Link 01/2016 - 10/2007
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2013 - 05/2004
5	dupilumabIBA 08/2022 - 04/2021
5	Biological ProductsIBA 01/2021 - 09/2015
5	CytokinesIBA 01/2018 - 11/2000
4	Proteins (Proteins, Gene)FDA Link 06/2017 - 11/2000
4	Type A Botulinum Toxins (Botox)FDA Link 01/2014 - 12/2004
3	Adalimumab (Humira)FDA Link 01/2021 - 06/2015
3	3-ingenyl angelateIBA 03/2020 - 09/2016
3	LipidsIBA 07/2013 - 10/2007
3	Insulin (Novolin)FDA Link 07/2013 - 10/2007
2	risankizumabIBA 02/2022 - 03/2021
2	Interleukin-4 (Interleukin 4)IBA 08/2021 - 12/2014
2	Rifampin (Rifampicin)FDA LinkGeneric 01/2021 - 08/2012
2	Clindamycin (Cleocin)FDA LinkGeneric 01/2021 - 12/2020
2	Interleukin-13IBA 01/2018 - 11/2000
2	Infliximab (Remicade)FDA Link 01/2016 - 08/2015
2	Pharmaceutical PreparationsIBA 08/2015 - 10/2013
2	Interleukin-6 (Interleukin 6)IBA 12/2014 - 10/2007
2	incobotulinumtoxinA FDA Link 01/2014 - 10/2013
2	Ficusin (Psoralen)IBA 07/2013 - 05/2012
2	TeicoplaninIBA 11/2012 - 05/2011
2	Chemokine CCL27IBA 05/2012 - 12/2007
2	AntioxidantsIBA 01/2012 - 09/2011
2	Matrix Metalloproteinases (MMPs)IBA 04/2011 - 03/2001
1	COVID-19 VaccinesIBA 11/2021
1	VaccinesIBA 11/2021
1	Monoclonal AntibodiesIBA 08/2021
1	LymecyclineIBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	resorcinol (resorcin)IBA 12/2020
1	Nicotinamide N-MethyltransferaseIBA 01/2020
1	Omalizumab (Xolair)FDA Link 05/2019
1	HLA-C*06 antigenIBA 01/2019
1	secukinumabIBA 01/2019
1	Interleukin-12 (IL 12)IBA 01/2018
1	InterleukinsIBA 01/2018
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2018
1	Interleukin-17 (Interleukin 17)IBA 01/2018
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2018
1	CarbohydratesIBA 05/2017
1	CholesterolIBA 05/2017
1	Triglycerides (Triacylglycerol)IBA 05/2017
1	Certolizumab Pegol FDA Link 01/2017
1	Ustekinumab (CNTO 1275)FDA Link 01/2016
1	HomocysteineIBA 09/2015
1	Immunologic Factors (Immunomodulators)IBA 08/2015
1	Prostaglandins AIBA 06/2015
1	Interleukin-2 (IL2)IBA 12/2014
1	Interleukin-8 (Interleukin 8)IBA 12/2014
1	interleukin-21 (interleukin 21)IBA 12/2014
1	onabotulinum toxin AIBA 01/2014
1	Hyaluronic Acid (Hyaluronan)IBA 09/2013

Therapy/Procedure

9	Therapeutics 04/2021 - 12/2004
5	Biological Therapy 12/2020 - 07/2012
4	Injections 01/2014 - 09/2004
3	Intradermal Injections 01/2014 - 08/2011
3	Aftercare (After-Treatment) 01/2014 - 08/2011
1	Caloric Restriction 05/2017
1	Palliative Care (Palliative Therapy) 05/2014